Inozyme Pharma Inc <INZY.OQ> expected to post a loss of 41 cents a share - Earnings Preview
Inozyme Pharma Inc INZY.OQ INZY.O is expected to show no change in quarterly revenue when it reports results on March 10 (estimated) for the period ending December 31 2024
LSEG's mean analyst estimate for Inozyme Pharma Inc is for a loss of 41 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Inozyme Pharma Inc is $15.50, above its last closing price of $1.23.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.44 | -0.44 | -0.39 | Beat | 10.5 |
Jun. 30 2024 | -0.39 | -0.39 | -0.44 | Missed | -13 |
Mar. 31 2024 | -0.36 | -0.36 | -0.38 | Missed | -5.6 |
Dec. 31 2023 | -0.34 | -0.32 | -0.33 | Missed | -3.6 |
Sep. 30 2023 | -0.31 | -0.32 | -0.29 | Beat | 8.3 |
Jun. 30 2023 | -0.40 | -0.43 | -0.35 | Beat | 19.2 |
Mar. 31 2023 | -0.44 | -0.45 | -0.40 | Beat | 10.3 |
Dec. 31 2022 | -0.42 | -0.45 | -0.42 | Beat | 7 |
This summary was machine generated March 7 at 13:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Investing in Clean Energy
TradingKey - Not so long ago, clean energy was relegated to a niche, a corner for subsidies, early markets, and greens. Now it's at the center of global economic thought. Governments, business, and consumers are driving a structural transformation from fossil fuels to renewables. The roofs are toppe
Investing in Luxury & Experiential Consumption
Niche assets like data centers, logistics, healthcare, and cold storage thrive on structural drivers, not traditional property cycles Specialized real estate benefits from secular trends like digitalization, demographics, and supply chain innovation, making demand resilient and less cycle-sensitive
Investing in Specialized Real Estate
TradingKey - Niche assets like data centers, logistics, healthcare, and cold storage thrive on structural drivers, not traditional property cycles Specialized real estate benefits from secular trends like digitalization, demographics, and supply chain innovation
Investing in Gaming & Digital Entertainment
TradingKey - Video gaming and digital entertainment have moved from on the margin of leisure to at the heart of global culture. What was formerly considered a niche entertainment, gaming now rivals and at times dominates movie and music revenue. Meanwhile, streaming services, cyber sports
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
